Leveraging synergies with other ATS Life Sciences Group companies, Scientific Products is creating solutions that positively impact lives worldwide
PHYSICO-CHEMICAL ANALYSIS ON RICE
Sample management specialists – Ziath (www.ziath.com) announced their acquisition by Azenta Inc (Burlington, MA, USA)
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, and Element Biosciences, Inc., developer of a new DNA sequencing platform disrupting genomics, today announced a partnership to demonstrate the capabilities of the Bio-Rad SEQuoia RNA Sequencing Library Preparation portfolio on the Element AVITI™ Benchtop Sequencer.
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, has developed partnerships with leading innovative next-generation sequencing (NGS) instrument providers and announces compatibility of the SEQuoia RNA Sequencing Library Preparation portfolio on new state-of-the-art sequencers, including the Singular Genomics G4™ System.
DP5 is the latest version of Ziath’s market leading 2D rack decoding software. Drawing upon the latest technologies, DP5 can be run from a laptop, desktop, phone, tablet, or any other network connected device. Using high-speed, web-based, communications protocols – DP5 allows users to run a single scanner in the lab, or multiple scanners connected […]
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced the launch of the CFX Opus Deepwell Dx Real-Time PCR System, a real-time PCR system listed with the U.S. Food and Drug Administration (FDA) for in vitro diagnostic (IVD) testing, and developed in accordance with […]
The Scandinavian Biotech company, Tetra Pharm Technologies has secured €9M in a series A round led by a group of Danish investors. The company, with operations in Copenhagen, Denmark focuses on therapeutics targeting the endocannabinoid system to treat neuropathic pain and mental health disorders.
ISO 13485 is an internationally recognized standard that sets out the requirements for a quality management system for the medical device industry. Our certificate has been awarded for the design, development, manufacture, contract manufacture, distribution, and support of high-performing reagents for genomic applications in medical research.
Swedish cancer detection company Elypta has published groundbreaking research showcasing the multi-cancer early detection (MCED) potential of glycosaminoglycans as biomarkers of tumour metabolism. The research conducted at Chalmers University of Technology by Elypta founders Prof. Jens Nielsen and Dr Francesco Gatto has been published in Proceedings of the National Academy of Sciences (PNAS). doi: https://doi.org/10.1073/pnas.2115328119
November 2025
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.